Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 169

1.

BACT-01 - La formation de biofilm par P. aeruginosa par les antibiotiques est inductible et réversible.

Olivares E, Clerigué Louzado J, Badel-Berchoux S, Provot C, Jauhlac B, Prévost G, Bernardi T, Jehl F.

Med Mal Infect. 2016 Jun;46(4 Suppl 1):19. doi: 10.1016/S0399-077X(16)30296-7. French. No abstract available.

PMID:
27495433
3.

The BioFilm Ring Test: a Rapid Method for Routine Analysis of Pseudomonas aeruginosa Biofilm Formation Kinetics.

Olivares E, Badel-Berchoux S, Provot C, Jaulhac B, Prévost G, Bernardi T, Jehl F.

J Clin Microbiol. 2016 Mar;54(3):657-61. doi: 10.1128/JCM.02938-15. Epub 2015 Dec 30.

4.

Towards a definition of daptomycin optimal dose: Lessons learned from experimental and clinical data.

Senneville E, Caillon J, Calvet B, Jehl F.

Int J Antimicrob Agents. 2016 Jan;47(1):12-9. doi: 10.1016/j.ijantimicag.2015.11.005. Epub 2015 Nov 29. Review.

PMID:
26712134
5.

Susceptibility trends including emergence of linezolid resistance among coagulase-negative staphylococci and meticillin-resistant Staphylococcus aureus from invasive infections.

Decousser JW, Desroches M, Bourgeois-Nicolaos N, Potier J, Jehl F, Lina G, Cattoir V, Vandenesh F, Doucet-Populaire F; Microbs Study Group.

Int J Antimicrob Agents. 2015 Dec;46(6):622-30. doi: 10.1016/j.ijantimicag.2015.07.022. Epub 2015 Sep 25.

PMID:
26453147
6.

In vivo macrophage imaging using MR targeted contrast agent for longitudinal evaluation of septic arthritis.

Bierry G, Lefevre S, Dietemann JL, Jehl F.

J Vis Exp. 2013 Oct 20;(80):e50296. doi: 10.3791/50296.

7.

Multicomponent antibiotic substances produced by fermentation: implications for regulatory authorities, critically ill patients and generics.

Brink AJ, Richards GA, Colombo G, Bortolotti F, Colombo P, Jehl F.

Int J Antimicrob Agents. 2014 Jan;43(1):1-6. doi: 10.1016/j.ijantimicag.2013.06.013. Epub 2013 Aug 3. Review.

PMID:
23920094
8.

Cateslytin, a chromogranin A derived peptide is active against Staphylococcus aureus and resistant to degradation by its proteases.

Aslam R, Marban C, Corazzol C, Jehl F, Delalande F, Van Dorsselaer A, Prévost G, Haïkel Y, Taddei C, Schneider F, Metz-Boutigue MH.

PLoS One. 2013 Jul 24;8(7):e68993. doi: 10.1371/journal.pone.0068993. Print 2013.

9.

In vitro activity of daptomycin against Enterococcus faecalis under various conditions of growth-phases, inoculum and pH.

Argemi X, Hansmann Y, Christmann D, Lefebvre S, Jaulhac B, Jehl F.

PLoS One. 2013 May 21;8(5):e64218. doi: 10.1371/journal.pone.0064218. Print 2013.

10.

Prevalence of mupirocin resistance among invasive coagulase-negative staphylococci and methicillin-resistant Staphylococcus aureus (MRSA) in France: emergence of a mupirocin-resistant MRSA clone harbouring mupA.

Desroches M, Potier J, Laurent F, Bourrel AS, Doucet-Populaire F, Decousser JW; Microbs Study Group.

J Antimicrob Chemother. 2013 Aug;68(8):1714-7. doi: 10.1093/jac/dkt085. Epub 2013 Mar 27.

11.

Efficacy of intravitreal administrations of linezolid in an experimental model of S. aureus-related endophthalmitis.

Saleh M, Lefèvre S, Acar N, Bourcier T, Marcellin L, Prévost G, Subilia A, Gaucher D, Jehl F.

Invest Ophthalmol Vis Sci. 2012 Jul 20;53(8):4832-41. doi: 10.1167/iovs.11-8417.

PMID:
22661478
12.

Daptomycin versus vancomycin in a methicillin-resistant Staphylococcus aureus endophthalmitis rabbit model: bactericidal effect, safety, and ocular pharmacokinetics.

Lefèvre S, Saleh M, Marcellin L, Subilia A, Bourcier T, Prévost G, Jehl F.

Antimicrob Agents Chemother. 2012 May;56(5):2485-92. doi: 10.1128/AAC.05745-11. Epub 2012 Feb 27.

13.

Ocular penetration of linezolid after oral administration in rabbits.

Saleh M, Lefevre S, Bourcier T, Prevost G, Gaucher D, Speeg-Schatz C, Jehl F.

J Ocul Pharmacol Ther. 2011 Jun;27(3):243-6. doi: 10.1089/jop.2010.0157. Epub 2011 Apr 21.

PMID:
21510740
14.

Comparative activity of carbapenem testing: the COMPACT study.

Nordmann P, Picazo JJ, Mutters R, Korten V, Quintana A, Laeuffer JM, Seak JC, Flamm RK, Morrissey I; COMPACT study group.

J Antimicrob Chemother. 2011 May;66(5):1070-8. doi: 10.1093/jac/dkr056. Epub 2011 Mar 8.

15.

Septic arthritis: monitoring with USPIO-enhanced macrophage MR imaging.

Lefevre S, Ruimy D, Jehl F, Neuville A, Robert P, Sordet C, Ehlinger M, Dietemann JL, Bierry G.

Radiology. 2011 Mar;258(3):722-8. doi: 10.1148/radiol.10101272.

PMID:
21339348
16.

Enhanced physician adherence to antibiotic use guidelines through increased availability of guidelines at the time of drug ordering in hospital setting.

Westphal JF, Jehl F, Javelot H, Nonnenmacher C.

Pharmacoepidemiol Drug Saf. 2011 Feb;20(2):162-8. doi: 10.1002/pds.2078. Epub 2010 Dec 23.

PMID:
21254287
17.

MRI of macrophages in infectious knee synovitis.

Bierry G, Jehl F, Neuville A, Lefevre S, Robert P, Kremer S, Dietemann JL.

AJR Am J Roentgenol. 2010 Jun;194(6):W521-6. doi: 10.2214/AJR.09.3768.

PMID:
20489072
18.

[Comparative study of Vitek-2™ AIX versus Vitek-2™ PC: phenotypic resistance of enterobacteriaceae to β-lactams].

Lefèvre S, Cocquerelle V, Riegel P, Scheftel JM, Jaulhac B, Jehl F.

Pathol Biol (Paris). 2012 Apr;60(2):78-83. doi: 10.1016/j.patbio.2010.01.002. Epub 2010 Apr 7. French.

PMID:
20378278
19.

Ocular penetration of topically applied linezolid in a rabbit model.

Saleh M, Jehl F, Dory A, Lefevre S, Prevost G, Gaucher D, Sauer A, Speeg-Schatz C, Bourcier T.

J Cataract Refract Surg. 2010 Mar;36(3):488-92. doi: 10.1016/j.jcrs.2009.09.036.

PMID:
20202550
20.

[Extension of antimicrobial drugs resistance: two clinical isolates of Klebsiella pneumoniae with cephalosporinase].

Gueudet T, Richter S, Szulc M, Jehl F.

Med Mal Infect. 2010 Mar;40(3):177-9. doi: 10.1016/j.medmal.2009.08.004. Epub 2009 Oct 1. French. No abstract available.

PMID:
19800186
Items per page

Supplemental Content

Loading ...
Write to the Help Desk